Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5230481 | 6231777 | I | 5230481-5 | 20051028 | 20070123 | 20070206 | EXP | PHBS2007FR01376 | NOVARTIS PHARMACEUTICALS CORP. | 63 | YR | F | Y | 74 | KG | 20070202 | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5230481 | 1008120015 | C | DIFFU K | 2 | ORAL | ||||||
| 5230481 | 1008120016 | C | PERINDOPRIL ERBUMINE | 1 | ORAL | ||||||
| 5230481 | 1008120017 | C | LEVOTHYROXINE SODIUM | 1 | ORAL | ||||||
| 5230481 | 1008120018 | PS | LOGROTON | 2 | ORAL | 017963 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5230481 | 1008120018 | HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5230481 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5230481 | CEREBROVASCULAR ACCIDENT |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5230481 | 1008120015 | 20040101 | |||
| 5230481 | 1008120016 | 20000101 | |||
| 5230481 | 1008120017 | 20041201 | |||
| 5230481 | 1008120018 | 19850101 |